225 related articles for article (PubMed ID: 29872297)
1. Modeling the neuron as a nanocommunication system to identify spatiotemporal molecular events in neurodegenerative disease.
Banerjee A; Paluh JL; Mukherjee A; Kumar KG; Ghosh A; Naskar MK
Int J Nanomedicine; 2018; 13():3105-3128. PubMed ID: 29872297
[TBL] [Abstract][Full Text] [Related]
2. Dendritic and axonal mechanisms of Ca2+ elevation impair BDNF transport in Aβ oligomer-treated hippocampal neurons.
Gan KJ; Silverman MA
Mol Biol Cell; 2015 Mar; 26(6):1058-71. PubMed ID: 25609087
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons.
Ramser EM; Gan KJ; Decker H; Fan EY; Suzuki MM; Ferreira ST; Silverman MA
Mol Biol Cell; 2013 Aug; 24(16):2494-505. PubMed ID: 23783030
[TBL] [Abstract][Full Text] [Related]
4. Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-β oligomer-treated hippocampal neurons.
Takach O; Gill TB; Silverman MA
Neurobiol Aging; 2015 Mar; 36(3):1378-82. PubMed ID: 25543463
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-Beta Modulates Low-Threshold Activated Voltage-Gated L-Type Calcium Channels of Arcuate Neuropeptide Y Neurons Leading to Calcium Dysregulation and Hypothalamic Dysfunction.
Ishii M; Hiller AJ; Pham L; McGuire MJ; Iadecola C; Wang G
J Neurosci; 2019 Oct; 39(44):8816-8825. PubMed ID: 31537707
[TBL] [Abstract][Full Text] [Related]
6. Low Levels of Brain-Derived Neurotrophic Factor Trigger Self-aggregated Amyloid β-Induced Neuronal Cell Death in an Alzheimer's Cell Model.
Tagai N; Tanaka A; Sato A; Uchiumi F; Tanuma SI
Biol Pharm Bull; 2020; 43(7):1073-1080. PubMed ID: 32612070
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
[TBL] [Abstract][Full Text] [Related]
8. β-Amyloid impairs axonal BDNF retrograde trafficking.
Poon WW; Blurton-Jones M; Tu CH; Feinberg LM; Chabrier MA; Harris JW; Jeon NL; Cotman CW
Neurobiol Aging; 2011 May; 32(5):821-33. PubMed ID: 19540623
[TBL] [Abstract][Full Text] [Related]
9. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
[TBL] [Abstract][Full Text] [Related]
11. Imaging organelle transport in primary hippocampal neurons treated with amyloid-β oligomers.
Gan KJ; Silverman MA
Methods Cell Biol; 2016; 131():425-51. PubMed ID: 26794527
[TBL] [Abstract][Full Text] [Related]
12. Calcium signaling in Alzheimer's disease & therapies.
Tong BC; Wu AJ; Li M; Cheung KH
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons.
Decker H; Lo KY; Unger SM; Ferreira ST; Silverman MA
J Neurosci; 2010 Jul; 30(27):9166-71. PubMed ID: 20610750
[TBL] [Abstract][Full Text] [Related]
14. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease.
Wong J; Higgins M; Halliday G; Garner B
Neuroscience; 2012 May; 210():363-74. PubMed ID: 22426239
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of β-amyloid protein: oligomerization, channel formation, and calcium dyshomeostasis.
Kawahara M
Curr Pharm Des; 2010; 16(25):2779-89. PubMed ID: 20698821
[TBL] [Abstract][Full Text] [Related]
17. Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.
Choi M; Lee Y; Cho SH
Chin J Integr Med; 2018 May; 24(5):378-384. PubMed ID: 28578486
[TBL] [Abstract][Full Text] [Related]
18. Degradation Products of Amyloid Protein: Are They The Culprits?
Zaretsky DV; Zaretskaia M
Curr Alzheimer Res; 2020; 17(10):869-880. PubMed ID: 33272185
[TBL] [Abstract][Full Text] [Related]
19. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
